Sanofi (LON: 0A2V)
London
· Delayed Price · Currency is GBP · Price in USD 54.00
-0.60 (-1.10%)
At close: Jan 31, 2025
Sanofi Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | - | 5,400 | 8,371 | 6,223 | 12,294 | Upgrade
|
| Depreciation & Amortization | - | 3,610 | 3,365 | 3,001 | 3,186 | Upgrade
|
| Other Amortization | - | 120 | 97 | 119 | 112 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -226 | -573 | -357 | -1,012 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 1,062 | -42 | 231 | 373 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | -6,880 | Upgrade
|
| Loss (Gain) on Equity Investments | - | 295 | -48 | -15 | -339 | Upgrade
|
| Stock-Based Compensation | - | 283 | 245 | 244 | 274 | Upgrade
|
| Other Operating Activities | - | -1,086 | -295 | -389 | -301 | Upgrade
|
| Change in Accounts Receivable | - | -397 | -777 | 185 | -134 | Upgrade
|
| Change in Inventory | - | -840 | -927 | -357 | -593 | Upgrade
|
| Change in Accounts Payable | - | 402 | 452 | 451 | 86 | Upgrade
|
| Change in Other Net Operating Assets | - | 1,599 | 545 | 1,130 | 316 | Upgrade
|
| Operating Cash Flow | - | 10,258 | 10,526 | 10,522 | 7,418 | Upgrade
|
| Operating Cash Flow Growth | - | -2.55% | 0.04% | 41.84% | -3.85% | Upgrade
|
| Capital Expenditures | - | -1,719 | -1,606 | -1,478 | -1,254 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 1,015 | 1,488 | 676 | 918 | Upgrade
|
| Cash Acquisitions | - | -3,870 | -992 | -5,594 | -5,336 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -1,305 | -595 | -565 | -829 | Upgrade
|
| Investment in Securities | - | -92 | -354 | -269 | 10,233 | Upgrade
|
| Other Investing Activities | - | -229 | -16 | -68 | -113 | Upgrade
|
| Investing Cash Flow | - | -6,200 | -2,075 | -7,298 | 3,619 | Upgrade
|
| Short-Term Debt Issued | - | 765 | 215 | - | 282 | Upgrade
|
| Long-Term Debt Issued | - | 48 | 1,549 | - | 2,019 | Upgrade
|
| Total Debt Issued | - | 813 | 1,764 | - | 2,301 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -414 | - | Upgrade
|
| Long-Term Debt Repaid | - | -3,949 | -3,009 | -2,390 | -4,186 | Upgrade
|
| Total Debt Repaid | - | -3,949 | -3,009 | -2,804 | -4,186 | Upgrade
|
| Net Debt Issued (Repaid) | - | -3,136 | -1,245 | -2,804 | -1,885 | Upgrade
|
| Issuance of Common Stock | - | 195 | 188 | 186 | 203 | Upgrade
|
| Repurchase of Common Stock | - | -593 | -497 | -382 | -822 | Upgrade
|
| Common Dividends Paid | - | -4,454 | -4,168 | -4,008 | -3,937 | Upgrade
|
| Other Financing Activities | - | -64 | -99 | -48 | -44 | Upgrade
|
| Financing Cash Flow | - | -8,052 | -5,821 | -7,056 | -6,485 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -32 | 8 | 15 | -64 | Upgrade
|
| Net Cash Flow | - | -4,026 | 2,638 | -3,817 | 4,488 | Upgrade
|
| Free Cash Flow | - | 8,539 | 8,920 | 9,044 | 6,164 | Upgrade
|
| Free Cash Flow Growth | - | -4.27% | -1.37% | 46.72% | -3.57% | Upgrade
|
| Free Cash Flow Margin | - | 18.55% | 19.65% | 23.09% | 16.49% | Upgrade
|
| Free Cash Flow Per Share | - | 6.80 | 7.10 | 7.19 | 4.89 | Upgrade
|
| Cash Interest Paid | - | 559 | 380 | 334 | 315 | Upgrade
|
| Cash Income Tax Paid | - | 2,623 | 2,452 | 1,280 | 2,051 | Upgrade
|
| Levered Free Cash Flow | - | 8,189 | 9,009 | 7,336 | 6,284 | Upgrade
|
| Unlevered Free Cash Flow | - | 8,518 | 9,255 | 7,562 | 6,571 | Upgrade
|
| Change in Net Working Capital | 10,381 | -1,778 | -850 | -888 | -345 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.